A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens

Critical Care Medicine

Volumn 35, Issue 3, 2007, Pages 724-730

  Gold, Jeffrey A ^a   Rimal, Binaya ^b   Nolan, Anna ^b   Nelson, Lewis S ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK CITY POISON CONTROL CENTER   (United States)

Author keywords

Alcohol withdrawal; Benzodiazepines; Intensive care unit; Phenobarbital

Indexed keywords

BENZODIAZEPINE; PHENOBARBITAL;

ADULT; ALCOHOL WITHDRAWAL; ARTICLE; ARTIFICIAL VENTILATION; DELIRIUM TREMENS; DISEASE SEVERITY; DRUG DOSE ESCALATION; FEMALE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDATION;

ADULT; ALCOHOL WITHDRAWAL DELIRIUM; COHORT STUDIES; CROSS INFECTION; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, MUNICIPAL; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHENOBARBITAL; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES; PSYCHOMOTOR AGITATION; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; UTILIZATION REVIEW;

EID: 33947099124     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000256841.28351.80     Document Type: Article

References (43)

1. Caetano R, Clark CL, Greenfield TK: Prevalence, trends, and incidence of alcohol withdrawal symptoms: Analysis of general population and clinical samples. Alcohol Health Res World 1998; 22:73-79
2. Foy A, Kay J, Taylor A: The course of alcohol withdrawal in a general hospital. QJM 1997; 90:253-261
3. Spies CD, Dubisz N, Neumann T, et al: Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: Results of a prospective, randomized trial. Crit Care Med 1996; 24:414-422
4. Daeppen JB, Gache P, Landry U, et al: Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: A randomized treatment trial. Arch Intern Med 2002; 162:1117-1121
5. Saitz R, Mayo-Smith MF, Roberts MS, et al: Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA 1994; 272:519-523
6. Mayo-Smith MF, Beecher LH, Fischer TL, et al: Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004; 164:1405-1412
7. Thompson WL, Johnson AD, Maddrey WL: Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med 1975; 82:175-180
8. Marik P, Mohedin B: Alcohol-related admissions to an inner city hospital intensive care unit. Alcohol Alcohol 1996; 31:393-396
9. Dill C, Shin S: High-dose intravenous benzodiazepine. Acad Emerg Med 2000; 7:308-310
10. Nolop KB, Natow A: Unprecedented sedative requirements during delirium tremens. Crit Care Med 1985; 13:246-247
11. Coomes TR, Smith SW: Successful use of propofol in refractory delirium tremens. Ann Emerg Med 1997; 30:825-828
12. McCowan C, Marik P: Refractory delirium tremens treated with propofol: a case series. Crit Care Med 2000; 28:1781-1784
13. Spies CD, Nordmann A, Brummer G, et al: Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol Scand 1996; 40:649-656
14. Spies CD, Otter HE, Huske B, et al: Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med 2003; 29:2230-2238
15. First MB: Diagnostic and Statistical Manual of Mental Disorders. Text Revision. Washington, DC, American Psychiatric Association, 2000
16. Charney D, Mihi SC, Harris R: Hypnotics and sedatives. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics. Tenth Edition. Hardman J, Limbird L (Eds). New York, McGraw-Hill, 2001
17. Riker RR, Picard JT, Fraser GL: Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27:1325-1329
18. Rello J, Paiva JA, Baraibar J, et al: International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia. Chest 2001; 120:955-970
19. Kaim SC, Klett CJ, Rothfeld B: Treatment of the acute alcohol withdrawal state: A comparison of four drugs. Am J Psychiatry 1969; 125:1640-1646
20. Hack J, Hoffman R, Nelson L: Resistant alcohol withdrawal: Does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2006; 2:55-60
21. Allan AM, Harris RA: Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels. Pharmacol Biochem Behav 1987; 27:665-670
22. Cagetti E, Liang J, Spigelman I, et al: Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol Pharmacol 2003; 63:53-64
23. Follesa P, Biggio F, Talani G, et al: Neurosteroids, GABA(A) receptors, and ethanol dependence. Psychopharmacology (Berl) 2006; 186:267-280
24. D'Onofrio G, Rathlev NK, Ulrich AS, et al: Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med 1999; 340:915-919
25. Wretlind M, Pilbrant A, Sundwall A, et al: Disposition of three benzodiazepines after single oral administration in man. Acta Pharmacol Toxicol (Copenh) 1977; 40(Suppl):28-39
26. Kraus ML, Gottlieb LD, Horwitz RI, Anscher M: Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313:905-909
27. Worner TM: Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: Double-blind controlled trial. Am J Drug Alcohol Abuse 1994; 20:115-124
28. Jacob MS, Zilm DH, MacLeod SM, et al: Propranolol-associated confused states during alcohol withdrawal. J Clin Psychopharmacol 1983; 3:185-187
29. Stanley KM, Amabile CM, Simpson KN, et al: Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes. Pharmacotherapy 2003; 23:843-854
30. Keaney F, Strang J, Gossop M, et al: A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: Lofexidine is not a useful adjunct to chlordiazepoxide. Alcohol Alcohol 2001; 36:426-430
31. Adinoff B: Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcohol Clin Exp Res 1994; 18:873-878
32. Blum K, Eubanks JD, JE Wallace, et al: Enhancement of alcohol withdrawal convulsions in mice by haloperidol. Clin Toxicol 1976; 9:427-434
33. Kramp P, Rafaelsen OJ: Delirium tremens: A double-blind comparison of diazepam and barbital treatment. Acta Psychiatr Scand 1978; 58:174-190
34. Ives TJ, Mooney AJ III, Gwyther RE: Pharmacokinetic dosing of phenobarbital in the treatment of alcohol withdrawal syndrome. South Med J 1991; 84:18-21
35. Amin J, Weiss DS: GABAA receptor needs two homologous domains of the beta-subunit for activation by GABA but not by pentobarbital. Nature 1993; 366:565-569
36. Macdonald RL, McLean MJ: Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 1982; 1(23 Suppl):S7-S18
37. Hoffman PL: Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metab Brain Dis 1995; 10:73-79
38. Daniell LC: Effect of anesthetic and convulsant barbiturates on N-methyl-D-aspartate receptor-mediated calcium flux in brain membrane vesicles. Pharmacology 1994; 49:296-307
39. Hans P, Bonhomme V, Collette J, et al: Propofol protects cultured rat hippocampal neurons against N-methyl-D-aspartate receptor-mediated glutamate toxicity. J Neurosurg Anesthesiol 1994; 6:249-253
40. Concas A, Santoro G, Mascia MP, et al: The general anesthetic propofol enhances the function of gamma-aminobutyric acid-coupled chloride channel in the rat cerebral cortex. J Neurochem 1990; 55:2135-2138
41. Hickey KS, Martin DF, Chuidian FX: Propofol-induced seizure-like phenomena. J Emerg Med 2005; 29:447-449
42. Wetterling T, Kanitz RD, Veltrup C, et al: Clinical predictors of alcohol withdrawal delirium. Alcohol Clin Exp Res 1994; 18:1100-1102
43. Gorwood P, Limosin F, Batel P, et al: The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 2003; 53:85-92